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The identification of genes that contribute to the susceptibilities to complex neuropsychiatric disorders such as schizophrenia, 
major depression and bipolar disorders has not been as successful using conventional genetic approaches as had been hoped. 
There are several problems associated with the conventional approaches, including the validity of psychiatric diagnosis itself, 
excluding carriers of relevant genes who cannot be identified in the absence of manifest symptoms, and the heterogeneity of 
neuropsychiatric disorders, both clinically and etiologically. A new direction that appears encouraging is the identification of 
neurobiological and neurobehavioural characteristics, hidden from the “naked eye” associated with these complex neuropsy-
chiatric disorders. These characteristics are termed endophenotypes, that may be more closely linked to gene expression in 
the causal chain from genes to psychiatric diagnosis disorders [1,2]. An endophenotype is a special kind of biomarker, one 
that is not the consequence of illness and is heritable. It plays an important role for bridging the gap between the microscopic 
level (e.g., molecular genetics) and the macroscopic level (e.g., clinical symptoms) of neuropsychiatric disorders such as 
schizophrenia and bipolar disorders [3,4]. The identification of endophenotypes is very crucial to the identification of genes 
that predispose someone to neuropsychiatric disorders. Therefore, the study of endophenotype is of particular usefulness for 
us to understand the underlying mechanism of the illness process of neuropsychiatric disorders, aiding the clinicians to make 
accurate diagnosis and for early detection purposes. The Director of the United States National Institute of Mental Health 
(NIMH), Thomas R. Insel and his associate Dr. Bruce N. Cuthbert have provided an ideal overview of the importance of en-
dophenotypes in the context of the mission of the NIMH [5] and have provided pointers [6] to exciting developments in re-
vising diagnostic practices that utilize endophenotypes. 
A substantial number of studies, especially of at-risk off-spring of patients, have suggested that neurocognitive dysfunc-
tions are among the most promising of the candidate endophenotypes. With the completion of the human genome project, the 
main hurdle for scientists working with neuropsychiatric disorders for the next decade will be how to characterize the mani-
fold human endophenotypes from the molecular level to the mind level, and most importantly, detecting unharmonious herit-
able contributors to the mind in neuropsychiatric disorders. The development of cognitive neurosciences, neuropsychology 
and imaging genetics—a strategy for mapping neural structures and brain activity as a function of genotype in living humans 
—has encouraged a conceptual transformation by showing that the greater power of endophenotypes lies in using genetic risk 
variants as tools for discovery of the mediating neural mechanisms that bridge the gap from DNA sequence to pathological 
behaviour. 
In October 11th–13th 2010, with support from the National Basic Research Program of China (973 Program) 
(2007CB512302), The Key Laboratory of Mental Health of the Institute of Psychology, Chinese Academy of Sciences has 
organized a strategic symposium for learning about endophenotypes, titled “Endophenotype strategy for psychotic disorders 
and summit meeting of Key Laboratory of Mental Health, Institute of Psychology, CAS”. It was a 3-d symposium taking 
place in Beijing. Participation was by invitation only, and a group of internationally renowned scholars and clinicians were  
 
        
Professor Irving I. Gottesman       A summit meeting of Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences 
3360 Chan R C K, et al.   Chinese Sci Bull   November (2011) Vol.56 No.32 
invited, including Prof. David Glahn from Yale Medical School, Prof. Bill Honer from University of British Columbia, Prof. 
Pak Sham from the University of Hong Kong, Prof. Bill Stone from Harvard Medical School, Dr. Paola Dazzan from the In-
stitute of Psychiatry (London), Dr. Grainne McAlonan from the University of Hong Kong, Dr. Xaolu Hsi from Boston, and 
Dr. Eric Cheung from Hong Kong as well as our local scholars and peer colleagues. Professor Irving Gottesman, the founder 
of the endophenotype concept and strategy for neuropsychiatric disorders, participated by giving a video-taped lecture to all 
the participants. 
The main purpose of this special topic is to document the work we have presented or will be doing in the area of endophe-
notypes for neuropsychiatric disorders, and to make the information available to a worldwide audience of neuroscientists and 
clinicians. In particular, this special issue comprises 9 papers—which were presented at the Symposium. The first 4 papers 
[7–10] are mainly focus on neuroanatomical and neuroimaging issues of endophenotypes for schizophrenia and related dis-
orders. Two papers [11,12] are working on the development of a battery specifically capturing neuropsychological endophe-
notypes for schizophrenia, and how it may help develop a research-oriented programme for studying endophenotypes for 
neuropsychiatric disorders. There are two papers [13,14] specifically dealing with the analysis issues including novel path-
way-based analysis for genome-wide association studies for schizophrenia, and the issues we should pay attention to when 
applying statistics for endophenotype study. Finally, there is one paper [15] working on the establishment of a consortium for 
endophenotypes to study neuropsychiatric disorders in mainland China. In particular, this paper illustrates a potential example 
using neurological soft signs in following the steps for building such a consortium.  
In sum, the use of endophenotypes is a powerful tool to index intermediate neurobiological processes that are influenced 
by genetic variation. It allows us to go through the most exciting period of studying complex neuropsychiatric disorders in the 
coming decade and to shed light on to the potential roles for contributing to this promising research field. 
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